Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 9NETWORK 2NIH 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 5Lymphoid 2Dermatologic 2Other solid neoplasm 1Gastrointestinal 1Breast 1

Conditions

Melanoma 2

Interventions

Interferon-alpha 6Radiosurgery 4Dacarbazine 4encorafenib 3binimetinib 3aldesleukin 3Watchful Waiting 3Radiotherapy 3Methotrexate 3Immunohistochemistry 3Gene Expression Profiling 3Filgrastim 3Etoposide 3Cyclophosphamide 3Cisplatin 3X-Rays 2Vincristine 2Vinblastine 2Temozolomide 2Specimen Handling 2Polymerase Chain Reaction 2Observation 2Nivolumab 2Ipilimumab 2Introns 2Interferon alpha-2 2Immunologic Techniques 2Flow Cytometry 2Carboplatin 2trametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Immunologic Techniques × Dermatologic × Clear all
NCT01388569 2017-05-17

Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim

Eastern Cooperative Oncology Group

Completed
48 enrolled
Dermatologic

Melanoma

NCT00755976 2014-12-31

Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma

Cancer Trials Ireland

Phase 2 Completed
32 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡